{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:01:42Z","timestamp":1786993302842,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journalofsubstanceabusetreatment.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jsat.2014.02.008","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T03:19:00Z","timestamp":1394767140000},"page":"35-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2107-0377","authenticated-orcid":false,"given":"Panagiotis","family":"Vagenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9929-7136","authenticated-orcid":false,"given":"Angela","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maua","family":"Herme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4956-1226","authenticated-orcid":false,"given":"Thomas","family":"Lincoln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Skiest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2014.02.008_bb0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs","volume":"376","author":"Altice","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2014.02.008_bb0010","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2014.02.008_bb0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.15288\/jsa.1995.56.423","article-title":"The Alcohol Use Disorders Identification Test (AUDIT): Validation of a screening instrument for use in medical settings","volume":"56","author":"Bohn","year":"1995","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"Suppl. 2","key":"10.1016\/j.jsat.2014.02.008_bb0020","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/381453","article-title":"Liver injury during highly active antiretroviral therapy: The effect of hepatitis C coinfection","volume":"38","author":"Bonacini","year":"2004","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2014.02.008_bb0025","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2014.02.008_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.15288\/jsas.2005.s15.157","article-title":"The COMBINE SAFTEE: A structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field","author":"Johnson","year":"2005","journal-title":"Journal of Studies on Alcohol. Supplement"},{"key":"10.1016\/j.jsat.2014.02.008_bb0035","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2014.02.008_bb0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1530-0277.2007.00593.x","article-title":"Hepatic safety of once-monthly injectable extended-release naltrexone administered to actively drinking alcoholics","volume":"32","author":"Lucey","year":"2008","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2014.02.008_bb0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.15288\/jsad.2012.73.991","article-title":"Hepatic safety of injectable extended-release naltrexone in patients with chronic hepatitis C and HIV infection","volume":"73","author":"Mitchell","year":"2012","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.jsat.2014.02.008_bb0050","author":"National Institutes of Health"},{"key":"10.1016\/j.jsat.2014.02.008_bb0055","first-page":"66","article-title":"Naltrexone hydrochloride (Trexan): A review of serum transaminase elevations at high dosage","volume":"67","author":"Pfohl","year":"1986","journal-title":"NIDA Research Monograph"},{"key":"10.1016\/j.jsat.2014.02.008_bb0060","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/j.1552-4604.1994.tb04002.x","article-title":"Lack of hepatotoxicity with naltrexone treatment","volume":"34","author":"Sax","year":"1994","journal-title":"Journal of Clinical Pharmacology"},{"issue":"Suppl. 20","key":"10.1016\/j.jsat.2014.02.008_bb0065","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2014.02.008_bb0070","doi-asserted-by":"crossref","first-page":"e7558","DOI":"10.1371\/journal.pone.0007558","article-title":"HIV\/AIDS among inmates of and releasees from US correctional facilities, 2006: Declining share of epidemic but persistent public health opportunity","volume":"4","author":"Spaulding","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jsat.2014.02.008_bb0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cct.2013.12.006","article-title":"Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community","volume":"37","author":"Springer","year":"2013","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.jsat.2014.02.008_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/00952990.2010.540280","article-title":"HIV, alcohol dependence, and the criminal justice system: A review and call for evidence-based treatment for released prisoners","volume":"37","author":"Springer","year":"2011","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2014.02.008_bb0085","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11524-010-9438-4","article-title":"Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: The impact of buprenorphine treatment","volume":"87","author":"Springer","year":"2010","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.jsat.2014.02.008_bb0090","doi-asserted-by":"crossref","first-page":"e38335","DOI":"10.1371\/journal.pone.0038335","article-title":"Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners","volume":"7","author":"Springer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jsat.2014.02.008_bb0095","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1530-0277.2011.01601.x","article-title":"Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone","volume":"36","author":"Tetrault","year":"2012","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2014.02.008_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.alcohol.2006.05.003","article-title":"Study of hepatotoxicity of naltrexone in the treatment of alcoholism","volume":"38","author":"Yen","year":"2006","journal-title":"Alcohol"}],"updated-by":[{"DOI":"10.1016\/j.jsat.2017.03.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000}}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214000415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214000415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T23:54:06Z","timestamp":1538783646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547214000415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0740547214000415"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2014.02.008","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2014.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}